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262Background: Minimally invasive mitral valve (MV) surgeries (ie, right thoracotomy and robotic approaches)
are preferred for degenerative mitral regurgitation because these procedures result in reduced surgical trauma
and recovery time. However, because of peripheral cardiopulmonary bypass, there is risk of embolic complica-
tions. We sought to use the strengths of 3-dimensional multidetector computed tomography (MDCT) in assess-
ing aortoiliac atherosclerosis and mitral annular calcification (MAC) and its influence on decision for approach
in MV surgery.
Methods: We included 141 patients with isolated grade 3 or 4þmitral regurgitation who underwent contrast-
enhancedMDCTof the chest, abdomen, and pelvis. Aortoiliac atherosclerosis was measured as circumferential-
ity (0 ¼ none, 1 ¼ less than one third, 2 ¼ one third to two thirds, and 3 ¼ more than two thirds) and thickness
(0¼ none or<1 mm, 1¼ 1 to 2.9 mm, 2¼ 3 to 5 mm, and 3¼>5 mm). Significant atherosclerosis was defined
as circumferentiality score 1 and/or thickness score 1. Circumferentiality of MAC was also measured in
a similar manner. Change in surgical approach was considered if a full/partial sternotomy was performed or sur-
gical procedure was cancelled.
Results: One hundred eleven (79%) patients (mean age, 54  11 years; 67% men) underwent minimally inva-
sive MV repair, whereas 30 patients (21%) had surgical approach changed (1 surgical cancellation). Of 111 pa-
tients who underwent minimally invasive repair, 4 (3.6%) patients had significant atherosclerosis/MAC,
whereas 26 (87%) patients had evidence of significant atherosclerosis/MAC in the changed approach group.
Conclusions: In patients undergoing minimally invasiveMV surgery, there is a strong association between pres-
ence of significant aortoiliac atherosclerosis, as determined by MDCT and/or MAC and change in surgical ap-
proach. (J Thorac Cardiovasc Surg 2013;146:262-8)Supplemental material is available online.
Myxomatous mitral valve (MV) disease is a common valve
abnormality often resulting in severe mitral regurgitation
(MR) with a natural history that is associated with signifi-
cant morbidity and mortality.1-3 Current clinical guidelines
recommend surgical correction for symptomatic patients,
but also for asymptomatic patients with various
associated imaging/clinical characteristics.4 From a treat-
ment standpoint, conventional, median sternotomy-basede Heart and Vascular Institutea and Imaging Institute,b Cleveland Clinic,
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The Journal of Thoracic and Cardiovascular Surgsurgical approaches yield excellent short- and long-term
results.5-7 More recently, less invasive approaches have
been introduced, including right-anterolateral thoracotomy
through a small incision and robotic MV repair, to reduce
surgical trauma, incision size, and postoperative
recovery time with excellent early and intermediate-term
results.8-11 However, limited intraoperative exposure
requires extensive modification of surgical technique. As
a result, selection of patients for minimally invasive
procedures depends on careful preoperative planning,
based on history, clinical examination, and multimodality
imaging.12 Mitral annular calcification (MAC) and ileofe-
moral arterial access are typically assessed by echocardiog-
raphy and invasive angiography, respectively. However, the
full extent of MAC and atherosclerosis are not well identi-
fied with these modalities.
The incremental value of pre-operative imaging with
multidetector computed tomography (MDCT) has been pre-
viously demonstrated.13,14 A particular strength of MDCT
is the assessment of vascular wall anatomy, especially
calcification. The identification and quantification of these
changes in the vessel wall without luminal stenosis is
the strength of 3-dimensional MDCT. Although theery c August 2013
Abbreviations and Acronyms
CT ¼ computed tomography
ECG ¼ electrocardiogram
MDCT ¼ multidetector computed tomography
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Dsignificance of these changes is incompletely understood,
their potential role in embolization with reversed aortic
flow should not be underestimated. However, it remains un-
clear if imaging identifies individual lesions with increased
risk for embolic events or overall patient risk. Based on
these data, thoracoabdominal aortic and iliac MDCT angi-
ography is routinely performed as part of the preoperative
assessment of our patients referred for robotically assisted
MV repair. This study evaluates the influence of preopera-
tive MDCT angiography in decision making regarding the
operative approach (minimally invasive vs standard surgi-
cal) in patients undergoing minimally invasive MV repair.
METHODS
Our retrospective observational study included consecutive patients with
grade3þMRwhowere referred to our center for possibleminimally invasive
MV repair using a robotic approach. Patients underwent a comprehensive
preoperative workup that included clinical evaluation, electrocardiogram,
routine laboratory testing, echocardiography, and coronary angiography.
In addition, all patients underwent contrast-enhancedMDCTof chest, abdo-
men, and pelvis.We excluded the following groups of patient fromour study
population: patients with noncontrast computed tomography (CT) or con-
traindications to iodinated contrast administration (allergy or renal dysfunc-
tion), patients with additional significant valvular lesions (1 valvular
regurgitation other than MR, and patients with>1 mitral stenosis), resting
atrial fibrillation on current electrocardiogram (ECG), known severe ob-
structive (>50%) epicardial coronary artery disease, history of prior cardio-
thoracic surgeries (coronary bypass grafting, valvular surgeries, cardiac
transplantation, or aortic surgeries), and known prior severe peripheral
arterial disease.
The final study population consisted of 141 patients who met the inclu-
sion/exclusion criteria. Standard demographic and clinical data were re-
corded. Preoperative New York Heart Association functional class was
also recorded. The study was performed after appropriate institutional re-
view board approval and waiver of individual informed consent.
The primary endpoint in this study was change in the intended surgical
procedure. Because these patients were specifically referred for minimally
invasive robotic surgery, they were preemptively screened and considered
at low risk. A change in intended surgical approach was defined as a recom-
mendation of a conventional full/partial sternotomy or cancellation of sur-
gical procedure (because of perceived increased risk related to robotic
surgery). The decision to change the surgical approach was made by the
surgeon after assessment of the individual patient’s MDCT findings. In
those patients who underwent MV surgery (robotic or conventional ap-
proach), postoperative in-hospital length of stay and 30-day events (includ-
ing death, stroke, and postoperative atrial fibrillation) were recorded as
secondary endpoints.
ECG Data
All patients underwent comprehensive ECG using commercially avail-
able instruments (HDI 5000, Philips Medical Systems, NA, Bothell, Wash,The Journal of Thoracic and Caand Acuson Sequoia, Siemens Medical Solutions USA, Inc, Malvern, Pa)
as part of standard preoperative workup. Left atrial volumes, left ventricu-
lar ejection fraction, and dimensions were measured according to previ-
ously described criteria.15 Degree of resting MR was assessed by color
Doppler and quantified according to multiple established criteria on a scale
of 0 to 4þ (0 ¼ none, 1þ¼ mild, 2þ¼ moderate, 3þ¼ moderately severe
and 4þ¼ severe).16 In addition, degree of MR and left ventricular ejection
fraction were recorded on predischarge resting ECG.
MDCT Data
All patients received scanning on a standard clinical MDCT scanner
(Philips Brilliance 256-slice scanner, Best, The Netherlands) after admin-
istration of an iodinated contrast agent (130 mL Ultravist 370, Bayer
Healthcare, Berlin, Germany) at 3.5 mL/second. The scans were acquired
in 2 parts: An initial prospective ECG-triggered axial scan from the level of
the thoracic inlet to the level of the diaphragm (after administration of 80 cc
contrast) followed by a second non-ECG gated spiral acquisition of the ab-
domen and pelvis, extending from the diaphragm to the midthigh (with an
additional administration of 50 cc iodinated contrast). The following pa-
rameters were applied: gantry rotation time ¼ 270 msec; patient-specific
beam collimation (96 to 128 3 0.625 mm); tube voltage ¼ 120 kVp;
beam pitch ¼ 0.625 (for the spiral scan). Images were reconstructed at
3-mm slice thickness. Dose length product, as a measure of radiation
dose (mGy 3 cm), was recorded for all patients.
Subsequently, all images were loaded on a dedicated workstation (Ter-
aRecon, San Francisco, Calif) for offline multiplanar 3-dimensional anal-
ysis. The investigator performing the MDCT analysis was blinded to each
patient’s clinical and operative status. Initially, the images were recon-
structed along the centerline of the aorta and pelvic arteries using manual
3-dimensional reconstruction (Figure 1). Measurements were performed
from true short-axis double oblique images, reconstructed orthogonal to
the vessel centerline. The window center and level were adjusted to reduce
the effect of calcium blooming on vessel measurements. The dimensions
of the aorta were measured at the following levels: aortic root, midascend-
ing aorta, midaortic arch, proximal descending aorta, suprarenal aorta, and
infrarenal aorta. The dimensions of the pelvic arteries were measured at
the level of the bilateral common iliac arteries, external iliac arteries,
and common femoral arteries. In addition, the location of aortic and pelvic
arterial atherosclerosis was recorded. Atherosclerotic changes were char-
acterized as obstructive (presence of>50% luminal stenosis by visual as-
sessment) or nonobstructive (absence of luminal stenosis by visual
assessment). Finally, the extent of atherosclerosis was semiquantitatively
measured as14: circumferentiality (0 ¼ none, 1 ¼ less than one-third cir-
cumference, 2 ¼ one-third to two-thirds circumference, and 3 ¼ more
than two-thirds circumference) and thickness (0 ¼ none or <1 mm,
1 ¼ 1 to 2.9 mm, 2 ¼ 3 to 5 mm, and 3 ¼>5 mm). We added the circum-
ferentiality and thickness score to generate an ‘‘atherosclerotic extent’’
score. In addition, atherosclerosis was classified as significant if circumfer-
entiality score>1 and/or thickness score 1 was identified in at least 1
vascular segment.
In addition, extent of MAC was recorded using short axis double-
oblique multiplanar reformatting of the heart at the level of mitral annu-
lus/MV, after appropriate adjustment of the window to reduce calcium
blooming (Figure E1). The following characteristics were recorded: max-
imal thickness in millimeters, measured from the leading anterior to the
trailing posterior edge at its greatest width (0 ¼ none, 1 ¼ <1 mm,
2 ¼ 1 to 4 mm and 3 ¼ 4 mm; and circumferentiality (0 ¼ none,
1¼ less than one-third circumference, 2 ¼ one-third to two-thirds circum-
ference, and 3 ¼ more than two-thirds circumference). Significant MAC
was defined as circumferentiality score>1 or thickness score 1.
MV Repair Technique
The various surgical MV repair techniques (sternotomy, partial sternot-
omy, and minimally invasive robotic approach) at our institution have beenrdiovascular Surgery c Volume 146, Number 2 263
FIGURE 1. Three-dimensional reconstructions of multidetector computed tomography scans of the aorta in a patient being evaluated for mitral valve sur-
gery. Top center, Volume-rendered reconstruction of the abdominal aorta and its pelvic branches reveal significant calcification near the aortic bifurcation
(arrow). Right, Multiplanar reconstruction of the right iliac arteries. Left, Multiplanar reconstruction of the left iliac arteries. Bottom center, An axial image
at the level of aortic bifurcation reveals partially circumferential calcific atherosclerosis.
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Ddescribed recently.11 Briefly, for robotic MV repair, cardiopulmonary by-
pass was established by cannulating the femoral artery and vein. After peri-
cardiotomy, the ascending aorta was occludedwith a transthoracic clamp or
an endoballoon. The left arm of the robot was inserted through the third in-
tercostal space near the anterior-axillary line and the right arm was inserted
through the fifth intercostal space in the midaxillary line. A minithoracot-
omy for the working port was placed in the fourth intercostal space in the
midaxillary line, and a dynamic left atrial retractor was placed in the mid-
clavicular line. The details of MV repair have been published in detail
elsewhere.11
Statistics
Baseline demographics, risk factors, and clinical variables were summa-
rized for the group. Continuous variables are expressed as a mean  stan-
dard deviation. Categorical data are presented using percentage
frequencies. Differences between groups were determined by using Stu-
dent t test or analysis of variance for continuous variables (Mann–Whitney
U test for nonparametric variables) and the c2 test for categorical variables.
In addition, logistic regression analysis was performed to test the associa-
tion between dependent variable (primary endpoint; that is, change in sur-
gical approach) and various potential predictors. For multivariable
regression analysis, predictors with P<.10 on univariable analysis were in-
cluded. Data assembly and statistical analysis was performed with SPSS
version 19 (IBM Corp, Armonk, NY).RESULTS
The baseline clinical characteristics of the study popula-
tion are shown in Table 1. All patients met New York Heart
Association Class I or II functional criteria for MV repair.264 The Journal of Thoracic and Cardiovascular SurgNo patient had glomerular filtration rate<60mL/kg/1.73m2.
No patient in the study population had obstructive coronary
atherosclerosis. The baseline ECG and MDCT char-
acteristics of the study population are shown in Table 2. Left
ventricular ejection fraction was preserved (55%) in 134
(95%) patients. In the remaining 7 (5%) patients, it was be-
tween 45% and 55%. In 54 (39%) patients, the left ventric-
ular end-diastolic dimensions were>5.5 cm. The average
time between MDCT and invasive coronary angiography
was at least 24 hours. The average time between invasive
coronary angiography and surgery was 48 hours. No patient
developed contrast-induced nephropathy in the study. No
patient had an interruption of the inferior vena cava. No pa-
tient had significant obstructive (>50% stenosis) disease of
the aorta or iliofemoral vasculature. Approximately 1 in 5
patients displayed evidence of significant atherosclerosis
of the aorta or its pelvic branches. The mean minimal lumi-
nal diameter of pelvic vasculature was similar in the groups
that underwent minimally invasive MV repair versus those
that had sternotomy (8.2 1.2 mm vs 7.8 2mm;P¼ .21).
Altogether, 30 patients (21%) had either significant athero-
sclerosis or MAC.
OUTCOMES
Of the study population, 111 (79%) underwent mini-
mally invasive robotic MV repair and all underwent theery c August 2013
TABLE 1. Baseline clinical characteristics of the study population
Variable
Total group
(n ¼ 141)
Robotic surgery group
(n ¼ 111)
Changed surgery group
(n ¼ 30) P value
Age (y) 54  11 51  11 63  11 <.001
Men 94 (67%) 79 (71%) 15 (50) .03
Body surface area (m2) 1.96  0.23 1.98  0.23 1.89  0.22 .07
Glomerular filtration rate (mL/min/1.73 m2) 86  16 87  16 82  15 .2
Hypertension 42 (30%) 28 (25%) 14 (47%) .02
Smoking (current or former) 51 (36%) 34 (31%) 17 (57%) .03
Diabetes mellitus 1 (0.7%) 0 1
Prior stroke 5 (4%) 4 (4%) 1 (3%) .9
Preoperative atrial fibrillation 22 (16%) 15 (14%) 7 (23%) .2
NYHA class
I 65 (46%) 54 (49%) 11 (37%) .12
II 59 (42%) 47 (42%) 12 (40%)
III 17 (12%) 10 (9%) 7 (23%)
IV 0 0 0
Data presented as mean  standard deviation or no. (%). NYHA, New York Heart Association.
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Dprocedure successfully. The remainder of the 29 patients
(21%) underwent an alternative surgical approach (partial
or a full sternotomy). Only 1 patient had the surgical proce-
dure entirely cancelled following the workup (this was dueTABLE 2. Imaging characteristics of the study population
Variable
Total group
(n ¼ 141)
Echocardiography
MR ( IIIþ) 141 (100%)
LA volume index (mL/m2) 31  14
LV–EDV index (cm/m2) 2.7  0.4
LV–ESV index (cm/m2) 1.7  0.3
LV ejection fraction (%) 59  5
RVSP 36  13
Multidetector computed tomography
Contrast dose (mL) 130  8
Significant MAC 10 (7%)
Aortic dimensions (mm)
Aortic root 36  4
Midascending 31  4
Aortic arch 27  3
Middescending 22  2
Suprarenal aorta 19  2
Midinfrarenal 17  2
Minimal luminal diameter of iliofemoral arteries (mm) 8  2
Distribution of any aortic atherosclerosis
Ascending 1 (2%)
Arch 3 (6%)
Descending 5 (10%)
Suprarenal 2 (4%)
Infrarenal 20 (38%)
Iliofemoral 22 (42%)
Atherosclerotic extent score 1.1  1.6
Significant aortoiliac atherosclerosis 28 (20%)
Data presented as mean standard deviation or no. (%).MR, Mitral regurgitation; LA, left a
right ventricular systolic pressure; MAC, mitral annular calcification.
The Journal of Thoracic and Cato severe comorbidities). Of the 28 patients with significant
atherosclerosis, 26 (93%) had a change in surgical ap-
proach to a sternotomy-based approach, whereas 2 pro-
ceeded with robotic MV repair (P< .001). Similarly, ofRobotic group
(n ¼ 111)
Changed surgery group
(n ¼ 30) P value
111 (100%) 30 (100%) .9
30  13 33  17 .2
2.7  0.4 2.8  0.5 .6
1.7  0.3 1.8  0.4 .2
59  5 59  5 .9
36  12 39  13 .2
130  10 130  2 .9
2 (2%) 8 (27%) <.001
36  4 35  4 .4
31  4 32  4 .5
27  3 27  3 .9
22  2 23  2 .5
19  2 19  3 .9
17  2 17  2 .9
8  2 7.8  1.2 .2
1 (1%) 0
0 3 (10%)
1 (1%) 4 (13%) <.001
0 2 (7%)
12 (11%) 8 (27%)
13 (12%) 9 (30%)
0.5  0.9 3.4  1.8 <.001
2 (2%) 26 (87%) <.001
trium; LV, left ventricle; EDV, end-diastolic volume; ESV, end-systolic volume; RVSP,
rdiovascular Surgery c Volume 146, Number 2 265
TABLE 3. Univariable and multivariable logistic regression analysis
to assess predictors of change in surgical approach for mitral valve
repair
Variable
Univariable Multivariable
Wald’s
statistic
P
value
Wald’s
statistic
P
value
Age 18.06 <.001 5.91 .02
Sex 4.61 .03
NYHA class 3.41 .07
Hypertension 5.00 .03
Smoking history 7.74 .005
Body mass index 0.37 .55
LV ejection fraction 0.89 .35
Indexed LA volume 1.61 .21
Indexed LV end-diastolic
diameter
0.29 .59
Significant atherosclerosis
or MAC
48.6 <.0001 29.38 <.0001
Minimal luminal caliber of
pelvic arteries
1.51 .22
NYHA, New York Heart Association; LV, left ventricle; LA, left atrium; MAC, mitral
annular calcification.
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surgical approach, whereas 2 did not (P<.001). Overall, 30
patients had significant atherosclerosis and/or MAC, of
which 26 (87%) had a change in surgical approach, whereas
4 did not (P<.001). The association between MDCT find-
ings and change in surgical approach is shown in Figure 2.
Table 3 shows various factors that were associated with
a change in surgical approach in the study population. Pres-
ence of significant atherosclerosis/MAC and increasing age
were associated with change in surgery from minimally in-
vasive to sternotomy-based approach. The surgical out-
comes (secondary endpoints) of the study population are
shown in Table E1. In our study population, there were no
30-day deaths in the robotic MV repair group; 1 patient in
the standard sternotomy group died during the postopera-
tive period as a result of multiorgan failure. One patient in
the robotic MV repair group developed left sided weakness
and speech problems on Postoperative Day 1. All his test-
ing, including neurologic tomography and invasive cerebral
angiography, were negative. His weakness resolved on
Postoperative Day 3 and hewas discharged without residual
effects. It was presumed to be embolic in nature. There were
no major bleeding/vascular complications requiring pro-
longed hospital stay. The average length of stay was signif-
icantly shorter for the robotic group (4.2  1.1 days),
compared with the sternotomy group (6.3  3.6 days;
P<.001).DISCUSSION
Our data demonstrate that in 21% of asymptomatic or
mildly symptomatic patients with severe MR referred for
robotic MV repair, a change to conventional surgical
approach occurred after comprehensive clinical evalua-
tion and MDCT angiography of the chest, abdomen, and
pelvis revealed significant subclinical aortoiliac athero-
sclerosis and/or MAC. These data could potentially beFIGURE 2. Association between change in surgical approach and pres-
ence of significant aortoiliac atherosclerosis and mitral annular calcifica-
tion (MAC).
266 The Journal of Thoracic and Cardiovascular Surgimportant to understand the need for preoperative imag-
ing in the context of novel robotic approaches to MV
repair.
The limited intraoperative exposure of the operative field
requires extensive modification of surgical technique, in-
cluding the approach to cardiopulmonary bypass and the
valve procedure itself. Cardiopulmonary bypass is estab-
lished in a retrograde fashion by cannulating the femoral ar-
tery and vein and occlusion of the ascending aorta with
either an endoballoon or clamp.11 The blood flow in the il-
iac arteries and aorta is subsequently reversed for brain per-
fusion. In patients with aortoiliac atherosclerotic disease,
peripheral cannulation and flow reversal has been shown
to be associated with an increases risk of embolic cerebro-
vascular complications.17 Hence, it would be important to
understand the atherosclerotic burden in patients being con-
sidered for retrograde brain perfusion during cardiac sur-
gery. However, the atherosclerotic disease burden in
patients referred for minimally invasive MV surgery is un-
known. One might argue that in a relatively young popula-
tion without significant comorbidities, prevalence of
atherosclerosis would be very low. However, in our study,
approximately 20% of patients had evidence of significant
(albeit nonobstructive) atherosclerosis of the thoracoabdo-
minal aorta or its iliofemoral branches, with a predomi-
nance of the infrarenal aorta or pelvic arteries.
Importantly, the minimal luminal caliber of pelvic arteries
was maintained, and there was no association between the
pelvic arterial luminal caliber and selection of surgical
approach.
The identification and quantification of these changes in
the vessel wall without luminal stenosis is the strength ofery c August 2013
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enhancedMDCTangiography. In contrast, conventional an-
giography lacks sensitivity for vessel wall changes because
of outward vessel wall remodeling.18 Although the signifi-
cance of these changes is incompletely understood, their po-
tential role in embolization with reversed aortic flow should
not be underestimated. However, it remains unclear if imag-
ing identifies individual lesions with increased risk for em-
bolic events or overall patient risk. In fact, recent research
supports the concept that atherosclerotic disease burden is
a marker for dismal outcome.14,19 Future studies will need
to define the role of noninvasive imaging. Similarly, extent
and location of MAC correlates with complexity of
repair. Therefore patients with extensive MAC are currently
not considered optimal candidates for robotic surgery.
Identification, precise localization, and quantification of
valvular calcification is a strength of CT and has been
demonstrated in valvular disease.20 One can argue that a non-
contrast CT could also be a viable option for assessment of
MAC and aortoiliac atherosclerosis. However, the ability of
contrast enhancement to assess luminal stenosis (in case of
a heavily calcific lesion) is far superior than that of a noncon-
trast CT. Furthermore, these are relatively young patientswith
preserved renal function where the likelihood of developing
renal failure is extremely low.One can alsomake an argument
for using transesophageal echocardiography and femoral
ultrasound to evaluate such patients, instead ofMDCT. How-
ever, doing transesophageal echocardiographypreoperatively
in all patients would unnecessarily add a semi-invasive test
with sedation. In most cases, an adequate quality transtho-
racic echo is deemed sufficient. All patients undergo intrao-
perative transesophageal echocardiography, but in our
opinion, a decision regarding the appropriate approach should
not be made in an operating room after intraoperative transe-
sophageal echocardiography, because it would provide a lo-
gistic problem of equipment (eg, sternotomy vs robotic
equipment) as well as operating room time. Femoral ultra-
sound, although an attractive option is not the best at assessing
nonobstructive calcific/noncalcific lesions. Its best utility is in
assessment of flow-limiting lesions. As shown in our study,
there were no flow-limiting lesions.
One might argue that use of MDCT could play a role in
evaluating older individuals (or younger patients with risk
factors for atherosclerosis) for subclinical atherosclerosis
before robotic MV repair. Indeed, in our study patients
who underwent the conventional surgical approach were
older with additional comorbidities, along with a higher
rate of postoperative atrial fibrillation and length of stay.
It further demonstrates the potential incremental prognostic
value of preoperative imaging with MDCT angiography,
which has previously been demonstrated in different patient
populations.13,14 A particular strength of MDCT in
preoperative imaging is the assessment of cardiovascular
calcification and vascular wall anatomy, in part because ofThe Journal of Thoracic and Cathe ability to reconstruct the 3-D data along unlimited
planes and the vessel centerline after image acquisition.
Because the natural history of severe myxomatous MR is
associated with significant morbidity and mortality, guide-
lines recommend surgical correction for asymptomatic pa-
tients with severe regurgitation and left ventricular
dilatation.4 Novel, less invasive surgical approaches, in-
cluding limited mini right-anterolateral thoracotomy and
robotic MV repair, are particularly attractive for asymptom-
atic or mildly symptomatic patients because of the reduced
surgical trauma, incision size, and postoperative recovery
time.8-11,21,22 However, in these patients, conventional,
median sternotomy-based surgical approaches are well es-
tablished and yield excellent short- and long-term results,
which sets an extremely high standard for novel proce-
dures.5-7 It is therefore critical to identify potential
contraindications for less invasive surgery before the
procedure, to preserve the safety and quality achieved by
surgery through complete sternotomy.
Strengths and Limitations
This was an observational study where the information
obtained on MDCT was used for clinical decision making,
particularly selection of the surgical approach. Hence, one
might argue that the significant association between
MDCT findings and change in surgical approach would
have been expected. The use of MDCT angiography has
to be weighed against the burden of nephrotoxicity and ra-
diation exposure. With state-of-the-art generation fast scan-
ners and diligent use of aggressive radiation-reduction
techniques, it is becoming less of an issue.23,24 Indeed, in
our study, we used prospective-triggered axial scanning
for the thoracic portion of the study and nongated imaging
through the abdomen and pelvis to achieve a mean radiation
dose of<10 mSeV. Newer-generation scanners have faster
gantry rotation times, so the dose of iodinated contrast can
be substantially reduced without notable compromise in im-
age quality. There are currently no definitive guidelines for
determining at what point, according toMDCT findings, ro-
botic surgery should be avoided. The primary aim of our
study was not to assess outcomes based on MDCT. The out-
comes of isolated MV repair (by all approaches, be it full
sternotomy, hemisternotomy, right thoracotomy, or robotic
approach) performed at our institution are very good—ap-
proaching 0%mortality. As a result, we would need a large
population with a very long follow-up to achieve any statis-
tical significance. Future prospective studies, randomizing
the approach for a given severity of aortoiliac atherosclero-
sis and/or MAC as determined by MDCT, would better
evaluate the benefits to preoperative imaging and its cost-
effectiveness. Because of the lack of a control group it re-
mains unclear if preoperative imaging is associated with
a reduction in complications such as stroke. We also did
not examine the potential role of the preoperative MDCTrdiovascular Surgery c Volume 146, Number 2 267
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quired at the same time with some changes to the acquisi-
tion protocol. That could have the added potential utility
of avoiding an invasive coronary angiogram.CONCLUSIONS
Our data demonstrates that subclinical aortic atheroscle-
rotic disease and MAC is frequently observed in patients
evaluated for robotic MV surgery. Preoperative MDCT
with aortoiliac angiography could enable precise assess-
ment of the extent of aortoiliac atherosclerosis and MAC,
especially in older patients (or those with increased risk
for atherosclerosis) and these findings are associated with
a recommended change in surgical approach from mini-
mally invasive robotic surgery to standard sternotomy-
based surgery. Future studies are needed to examine the
influence of MDCT angiography on decision making and
its cost-effectiveness in this population.References
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TABLE E1. Peri- and postoperative outcomes in the study population
Variable
Total population
(n ¼ 141)
Robotic surgery group
(n ¼ 111)
Changed surgery group
(n ¼ 30) P value
Pre-discharge mitral regurgitation
None 66 (47%) 48 (43%) 18 (60%)
Trivial 70 (50%) 59 (50%) 11 (37%) .1
Iþ 4 (3%) 3 (3%) 0
IIþ 2 (2%) 1 (1%) 1 (3%)
III-IVþ 0 0 0
Pre-discharge left ventricular ejection fraction (%) 53  5 54  5 53  6 .9
Postoperative atrial fibrillation, at the time of discharge 16 (11%) 7 (6%) 9 (30%) .001
Hospital length of stay (d) 4.6  2 4.2  1 6.3  4 <.001
Documented predischarge stroke 1 (0.7%) 1 (1%) 0 .5
30-day mortality 1 (0%) 0 (0%) 1 (0.3%) .6
Data presented as mean  standard deviation or no. (%).
FIGURE E1. A multiplanar reformatted image at the level of the mitral
valve reveals significant posterior annular calcification.
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